Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
Weight-loss drugs becoming better value for money, says watchdog
Popular GLP-1 weight-loss injections are now delivering greater value, according to a new report by a leading pharmaceutical…
Is LLY Underperforming the Healthcare Sector?
With a market cap of $694.9 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company headquartered…
Drugmaker halves price of Ozempic for Americans amid Trump crackdown
The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump…
Gai Kun of Kuaishou Concurrently Heads Keling AI Tech Dept, 360 Announces “All in Agent” Strategy, Tsinghua Team Makes Breakthrough in Quantum Computing
Large Companies: Mafengwo: AI itinerary planning function can automatically generate travel guides for users 36Kr learned that from…
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors…
Health Sector Sees Mixed Developments: Resolutions, Delays, and Innovations
The U.S. Food and Drug Administration announced a resolution to the nation’s saline shortage, a move easing…
ETFs in Focus on Eli Lilly’s Solid Q2 Earnings, Weak Obesity Data
Eli Lilly and Company LLY reported robust second-quarter 2025 results, wherein it beat estimates on both the top…
Novo Nordisk’s diabetes and weight loss drug sales growth decelerates
Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of…
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
President Trump’s tariffs could erode healthcare companies’ profits, but some may perform well regardless. Eli Lilly and Novartis…